Similar articles for PMID: 15599656

Year	Number of Results
1998	4
1999	2
2000	2
2001	3
2002	2
2003	2
2004	5
2005	3
2006	3
2007	3
2008	7
2009	8
2010	8
2011	3
2012	5
2013	4
2014	2
2015	4
2016	1
2024	0

1

Analysis of quasispecies in the viral 5' untranslated region of hepatitis C virus to evaluate ribavirin mutagenic effect in patients receiving ribavirin and interferon-alfa.

Vallejo A, Molina-Pinelo S, Abad MA, Gómez G, Leal M, Sánchez-Quijano A, Lissen E. Vallejo A, et al. Eur J Clin Microbiol Infect Dis. 2004 Dec;23(12):923-6. doi: 10.1007/s10096-004-1238-x. Eur J Clin Microbiol Infect Dis. 2004. PMID: 15599656

2

[Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].

Berg T, Kaul T, Naumann U, Wiedenmann B, Hopf U. Berg T, et al. Z Gastroenterol. 2000 Nov;38(11):881-6. doi: 10.1055/s-2000-10299. Z Gastroenterol. 2000. PMID: 11132533 Clinical Trial. German.

3

Evolution of hepatitis C virus quasispecies during ribavirin and interferon-alpha-2b combination therapy and interferon-alpha-2b monotherapy.

Arataki K, Kumada H, Toyota K, Ohishi W, Takahashi S, Tazuma S, Chayama K. Arataki K, et al. Intervirology. 2006;49(6):352-61. doi: 10.1159/000095155. Epub 2006 Aug 21. Intervirology. 2006. PMID: 16926548

4

Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.

Bronowicki JP, Ouzan D, Asselah T, Desmorat H, Zarski JP, Foucher J, Bourlière M, Renou C, Tran A, Melin P, Hézode C, Chevalier M, Bouvier-Alias M, Chevaliez S, Montestruc F, Lonjon-Domanec I, Pawlotsky JM. Bronowicki JP, et al. Gastroenterology. 2006 Oct;131(4):1040-8. doi: 10.1053/j.gastro.2006.07.022. Epub 2006 Jul 24. Gastroenterology. 2006. PMID: 17030174 Clinical Trial.

5

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. Fried MW, et al. N Engl J Med. 2002 Sep 26;347(13):975-82. doi: 10.1056/NEJMoa020047. N Engl J Med. 2002. PMID: 12324553 Free article. Clinical Trial.

6

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics.

González-Peralta RP, Kelly DA, Haber B, Molleston J, Murray KF, Jonas MM, Shelton M, Mieli-Vergani G, Lurie Y, Martin S, Lang T, Baczkowski A, Geffner M, Gupta S, Laughlin M; International Pediatric Hepatitis C Therapy Group. González-Peralta RP, et al. Hepatology. 2005 Nov;42(5):1010-8. doi: 10.1002/hep.20884. Hepatology. 2005. PMID: 16250032 Clinical Trial.

7

Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.

Sostegni R, Ghisetti V, Pittaluga F, Marchiaro G, Rocca G, Borghesio E, Rizzetto M, Saracco G. Sostegni R, et al. Hepatology. 1998 Aug;28(2):341-6. doi: 10.1002/hep.510280208. Hepatology. 1998. PMID: 9695995 Clinical Trial.

8

[Effect of interferon and ribavirin combination therapy in sixty-two patients with chronic hepatitis C originating from a single blood donor].

Liu SD, Cheng ML, Ren H, Yang QK, Shu DY. Liu SD, et al. Zhonghua Gan Zang Bing Za Zhi. 2012 Aug;20(8):589-92. doi: 10.3760/cma.j.issn.1007-3418.2012.08.010. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 23207152 Clinical Trial. Chinese.

9

Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.

Gallegos-Orozco JF, Fuentes AP, Olivera-Martinez MA, Gutiérrez-Reyes G, Cortina D, Oregel JA, Pérez-Pruna C, Sixtos MS, Cruz-Castellanos S, Soto-Ramírez LE, Rodríguez-Díaz R, Fuentes-Romero L, Gutiérrez-Ruiz MC, Kershenobich D. Gallegos-Orozco JF, et al. Rev Invest Clin. 2003 Mar-Apr;55(2):138-42. Rev Invest Clin. 2003. PMID: 12827916

10

A preliminary study on the efficacy and influencing factors of interferon for the treatment of genotype 1 chronic hepatitis C with different dosage forms.

Ma P, Yang JM, Hou W, Song SD, Wang L, Lu W. Ma P, et al. Eur J Gastroenterol Hepatol. 2013 May;25(5):601-5. doi: 10.1097/MEG.0b013e32835cc899. Eur J Gastroenterol Hepatol. 2013. PMID: 23263720 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

67 results

Results by year